Measured in a cell proliferation assay using MO7e human megakaryocytic leukemic cells. The ED50 for this effect is typically 0.5-5.0 ng/ml.
Lane 1: 3 μg of TPO, His, Human, non-reducing (NR)
Lane 2: 3 μg of TPO, His, Human, reducing (R)
> 95% as analyzed by SDS-PAGE
TPO, His, Human
Z03434 | |
|
|
$225.00 | |
|
|
|
|
Ask us a question |